Back
EU Parliament Roundtable - IBBIS
webCredibility Rating
4/5
High(4)High quality. Established institution or organization with editorial oversight and accountability.
Rating inherited from publication venue: International Biosecurity and Biosafety Initiative
Published by IBBIS, an organization promoting biosecurity screening standards; relevant to AI safety discussions around biological risks, dual-use research governance, and how international policy bodies approach catastrophic risk management in emerging technologies.
Metadata
Importance: 38/100organizational reportnews
Summary
This resource covers an IBBIS-associated EU Parliament roundtable discussion focused on balancing biosecurity measures with maintaining Europe's competitiveness in biotechnology. It likely addresses policy frameworks for dual-use research oversight, biosecurity screening, and how international coordination can manage biological risks without stifling innovation.
Key Points
- •Examines the tension between biosecurity requirements and biotechnology competitiveness in the EU context
- •Draws on EU Parliament roundtable discussions involving policymakers and biosecurity experts
- •IBBIS (International Biosecurity and Biosafety Initiative for Science) perspective on governance frameworks
- •Addresses dual-use research concerns and the need for international coordination on biosecurity screening
- •Relevant to AI safety insofar as AI-enabled bioweapons and biosecurity governance intersect
Cited by 1 page
| Page | Type | Quality |
|---|---|---|
| IBBIS (International Biosecurity and Biosafety Initiative for Science) | Organization | 60.0 |
Cached Content Preview
HTTP 200Fetched Apr 9, 20263 KB
Security and Competitiveness in Biotech: Insights from EU parliament roundtable - IBBIS
About
People
Careers
News
Our Work
Commec Sequence Screening
Customer Screening
Global Synthesis Map
International Standards
Sequence Biosecurity Standards
Vulnerability Disclosure
Contact
About
People
Careers
News
Our Work
Commec Sequence Screening
Customer Screening
Global Synthesis Map
International Standards
Sequence Biosecurity Standards
Vulnerability Disclosure
Contact
Security and Competitiveness in Biotech: Insights from EU parliament roundtable
IBBIS, the Pandemic Action Network , Pour Demain , and RAND Europe joined forces to co-host a high-level roundtable at the European Parliament, in collaboration with Member of the European Parliament (MEP) Hildegard Bentele (EPP, DE), rapporteur of the report The Future of the EU Biotechnology and Biomanufacturing Sector: Leveraging Research, Boosting Innovation, and Enhancing Competitiveness ( draft released March 21, 2025).
Bringing together senior experts from the European Commission, as well as MEPs across key political groups and committees, this roundtable aimed to shed light on:
The evolving biosecurity policy landscape within the EU and internationally
The intersection of synthetic biology and AI—its opportunities, challenges, and the policy pathways to bolster security while maintaining Europe’s competitive edge
Emerging risks, security challenges, and research implications, alongside proactive measures to mitigate potential threats
The pivotal role of funding mechanisms and international collaboration in strengthening biosecurity
Following insightful panel presentations, a dynamic and thought-provoking discussion unfolded, engaging policymakers, experts, industry leaders, and civil society representatives. A strong consensus emerged:
the EU must take a leadership role in ensuring that innovations in synthetic biology are underpinned by robust safeguards to mitigate biosecurity risks.
This engagement aligns with IBBIS’s ongoing global efforts to reinforce biosecurity in emerging biotechnologies. As part of our project assessing the biosecurity components of ISO 20688-2, we continue to work closely with government, industry, and academic stakeholders to drive best practices in DNA synthesis screening and promote responsible innovation.
We extend our sincere thanks to MEP Bentele and her team, as well as the distinguished speakers, including Olivier Girard, Head of Unit for Medical Counter-Measures at HERA, and Thomas Heynisch, from the Health Ecosystem Directorate at DG GROW, European Commission.
IBBIS remains committed to fostering collaboration and dialogue on biosecurity, ensuring that scientific progress serves humanity while adhering
... (truncated, 3 KB total)Resource ID:
f263f537e614f8ae | Stable ID: sid_kEfz8esX18